|
Market Analysis Reports of Sisunatovir
|
Respiratory syncytial virus infections - Pipeline Insight, 2021 ... phase III of development stage. Sisunatovir: ReViral Sisunatovir is an orally administered fusion ... . In Phase 1 clinical studies, sisunatovir showed excellent exposure with ... volunteers were reported in which sisunatovir produced statistically significant ...
Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Respiratory Syncytial ...
|
|
|